BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Liver cancer AND RBM10, GPATC9, 8241, ENSG00000182872, CTD-2522E6_5, GPATCH9, KIAA0122, P98175, MGC1132, DXS8237E, ZRANB5, MGC997 AND Staging
2129 results:

  • 1. [Study on mechanism of icariin-induced ferroptosis in HepG2 hepatoma carcinoma cells through PPARG/FABP4/GPX4 pathway].
    Li L; Zeng PH; Yang RY; Deng Y; He ZM; Xia X; Zhu DY; Peng QH
    Zhongguo Zhong Yao Za Zhi; 2024 Mar; 49(5):1295-1309. PubMed ID: 38621977
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Clinical usefulness of newly developed prognostic predictive score for atezolizumab plus bevacizumab for hepatocellular carcinoma.
    Ohama H; Hiraoka A; Tada T; Hirooka M; Kariyama K; Hatanaka T; Tani J; Takaguchi K; Atsukawa M; Itobayashi E; Nishimura T; Tsuji K; Tajiri K; Ishikawa T; Yasuda S; Toyoda H; Fukunishi S; Ogawa C; Kakizaki S; Shimada N; Naganuma A; Kawata K; Kosaka H; Kuroda H; Matono T; Yata Y; Ochi H; Tada F; Nouso K; Morishita A; Itokawa N; Okubo T; Arai T; Tsutsui A; Nagano T; Yokohama K; Nishikawa H; Imai M; Koizumi Y; Nakamura S; Iijima H; Kaibori M; Hiasa Y; Kumada T;
    Cancer Rep (Hoboken); 2024 Apr; 7(4):e2042. PubMed ID: 38577725
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Patient metabolic profile defined by liver and muscle
    Vitiello GA; Jayaprakasam VS; Tang LH; Schattner MA; Janjigian YY; Ku GY; Maron SB; Schoder H; Larson SM; Gönen M; Datta J; Coit DG; Brennan MF; Strong VE
    Gastric Cancer; 2024 May; 27(3):548-557. PubMed ID: 38436762
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. HCC-Check: A Novel Diagnostic Tool for Early Detection of Hepatocellular Carcinoma Based on Cytokeratin-1 and Epithelial Membrane Antigen: A Cross-Sectional Study.
    Attallah KA; Albannan MS; Farid K; Rizk SM; Fathy N
    Technol Cancer Res Treat; 2024; 23():15330338241234790. PubMed ID: 38436112
    [No Abstract]    [Full Text] [Related]  

  • 5. [The impact of modified T3 sub-staging on the prognosis of gallbladder cancer patients].
    Chen C; Zhang D; Li Q; Lei JJ; Geng ZM
    Zhonghua Wai Ke Za Zhi; 2024 Apr; 62(4):302-308. PubMed ID: 38432671
    [No Abstract]    [Full Text] [Related]  

  • 6. Integrating Navigation-Assisted Ablation in the Locoregional Treatment of Hepatocellular Carcinoma.
    Iwai Y; Agala CB; Gerber DA
    JAMA Netw Open; 2024 Feb; 7(2):e240694. PubMed ID: 38421644
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Split-bolus single-phase versus single-bolus split-phase CT acquisition protocols for staging in patients with testicular cancer: A retrospective study.
    O'Regan PW; Dewhurst C; O'Mahony AT; O'Regan C; O'Leary V; O'Connor G; Ryan D; Maher MM; Young R
    Radiography (Lond); 2024 Mar; 30(2):628-633. PubMed ID: 38330895
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Preoperative predictors for non-resectability in perihilar cholangiocarcinoma.
    Otto CC; Mantas A; Heij LR; Heise D; Dewulf M; Lang SA; Ulmer TF; Dahl E; Bruners P; Neumann UP; Bednarsch J
    World J Surg Oncol; 2024 Feb; 22(1):48. PubMed ID: 38326854
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. [Analysis of strong invasive clinical features and poor prognosis in macrotrabecular-massive hepatocellular carcinoma].
    Shan YY; Wang CN; Mao SQ; Yu X; Sun JN; Lu CD
    Zhonghua Gan Zang Bing Za Zhi; 2023 Dec; 31(12):1318-1325. PubMed ID: 38253077
    [No Abstract]    [Full Text] [Related]  

  • 10. Diagnostic yield of contrast-enhanced abdominal staging CT in patients with initially diagnosed breast cancer.
    Jeong B; Lee YW; Lee SB; Kim J; Chung IY; Kim HJ; Ko BS; Lee JW; Son BH; Gwark S; Shin HJ; Yoo TK; Choi SH
    Eur J Radiol; 2024 Feb; 171():111295. PubMed ID: 38241854
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. [Study on the comparison of postoperative liver injury caused by hepatic arterial perfusion chemotherapy combined with targeted immunotherapy with hepatic arterial chemoembolization combined with targeted immunotherapy for intermediate-and advanced-stage liver cancer].
    Li R; Li WL; Yuan GS; Pang HJ; Li Q; Hu XY; Guo YB; Chen JZ; Zang MY
    Zhonghua Gan Zang Bing Za Zhi; 2023 Nov; 31(11):1163-1168. PubMed ID: 38238949
    [No Abstract]    [Full Text] [Related]  

  • 12. Development and validation of web-based nomograms for predicting survival status in patients with intrahepatic cholangiocarcinoma depending on the surgical status: a SEER database analysis.
    Liu YG; Jiang ST; Zhang JW; Zhang L; Zhao HT; Sang XT; Lu X; Xu YY
    Sci Rep; 2024 Jan; 14(1):1568. PubMed ID: 38238494
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Treatment strategy for successful conversion surgery in clinical stage IVB gastric cancer.
    Hojo Y; Ishida Y; Tomita T; Kurahashi Y; Nakamura T; Kitayama Y; Nakao E; Kohno S; Murakami M; Takeuchi J; Takagawa T; Hirota S; Shinohara H
    Eur J Surg Oncol; 2024 Feb; 50(2):107314. PubMed ID: 38101115
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Clinical characteristics and prognosis of primary small cell carcinoma of the breast: a propensity score-matched, population-based study.
    Yin L; Yin AH; Pu CC
    BMJ Open; 2023 Dec; 13(12):e073841. PubMed ID: 38097248
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Improving prognostication in patients with hepatocellular carcinoma undergoing loco-regional therapy using pre- and post-locoregional therapy scores.
    Thandassery RB; Lavender CA; Perisetti A; Beheshti M
    Abdom Radiol (NY); 2024 Feb; 49(2):631-641. PubMed ID: 38071274
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Prognostic implications of alpha-fetoprotein and C-reactive protein elevation in hepatocellular carcinoma following resection (PACE): a large cohort study of 2770 patients.
    Lin KY; Chen QJ; Tang SC; Lin ZW; Zhang JX; Zheng SM; Li YT; Wang XM; Lu Q; Fu J; Guo LB; Zheng LF; You PH; Wu MM; Lin KC; Zhou WP; Yang T; Zeng YY
    BMC Cancer; 2023 Dec; 23(1):1190. PubMed ID: 38053048
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Should lymphadenectomy performed routinely in patients with primary intrahepatic cholangiocarcinoma undergoing curative hepatectomy? A retrospective cohort study with propensity-score matching analysis.
    Huang S; Song JL; Li B; Yi PS; Yang J
    BMC Surg; 2023 Nov; 23(1):364. PubMed ID: 38036995
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Navigating relapsed hepatoblastoma: Predictive factors and surgical treatment strategy.
    Espinoza AF; Patel KR; Shetty PB; Whitlock RS; Sumazin P; Yu X; Sarabia SF; Urbicain M; Heczey A; Masand P; Woodfield SE; López-Terrada DH; Vasudevan SA
    Cancer Med; 2023 Dec; 12(23):21270-21278. PubMed ID: 37962078
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. liver Transplantation for Hilar Cholangiocarcinoma.
    Sonnenday CJ
    Surg Clin North Am; 2024 Feb; 104(1):183-196. PubMed ID: 37953035
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Prognostic Value of Serum α-Fetoprotein Level as an Important Characteristic of Tumor Biology for Patients Undergoing liver Resection of Early-Stage Hepatocellular Carcinoma (BCLC Stage 0/A): A Large Multicenter Analysis.
    Yao LQ; Fan ZQ; Wang MD; Diao YK; Chen TH; Zeng YY; Chen Z; Wang XM; Zhou YH; Li J; Fan XP; Liang YJ; Li C; Shen F; Lv GY; Yang T
    Ann Surg Oncol; 2024 Feb; 31(2):1219-1231. PubMed ID: 37925654
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 107.